sever
lcwi
pocket
book
hospit
care
children
children
lower
chest
wall
indraw
lcwi
danger
signssign
respiratori
distress
without
hiv
sever
malnutrit
underli
condit
consid
nonsever
pneumonia
along
children
elev
respiratori
rate
recommend
home
care
sever
pneumonia
call
sever
pneumonia
pocketbook
hospit
care
young
infant
head
nod
specif
state
definit
sever
pneumonia
text
pocket
book
hospit
care
children
sever
respiratori
distress
elsewher
manual
head
nod
includ
sign
sever
respiratori
distress
page
defin
sever
respiratori
distress
fast
labor
breath
use
auxiliari
muscl
breath
head
nod
child
appear
tire
easili
abl
feed
respiratori
distress
head
nod
nasal
flare
specif
state
definit
sever
pneumonia
pocket
book
hospit
care
children
sever
respiratori
distress
elsewher
manual
page
eg
head
nod
nasal
flare
includ
sign
sever
respiratori
distress
occur
along
labor
fast
gasp
breath
page
defin
sever
respiratori
distress
breath
labour
fast
gasp
chest
indraw
nasal
flare
grunt
use
auxiliari
muscl
breath
head
nod
child
unabl
feed
respiratori
distress
tire
easili
multipl
prolong
convuls
appendix
caus
sever
pneumonia
requir
hospit
admiss
children
without
hiv
infect
africa
asia
perch
multicountri
casecontrol
studi
abbrevi
cxr
chest
radiograph
posit
consolid
andor
infiltr
analys
hiv
exposur
statu
restrict
south
africa
zambia
detail
inform
matern
hiv
statu
pregnanc
collect
matern
hiv
test
perform
enrol
data
mali
site
exclud
analysi
due
lack
standard
data
record
oxygen
use
gambia
base
evid
concurr
project
clinic
care
children
perch
code
receiv
oxygen
hypoxem
miss
data
hivuninfectedcxr
case
gambia
kenya
zambia
south
africa
bangladesh
thailand
abbrevi
cxr
abnorm
chest
radiograph
prior
exposur
antibiot
defin
posit
serum
bioassay
case
control
solid
bar
addit
case
hash
bar
serum
bioassay
neg
antibiot
identifi
receiv
antibiot
prior
specimen
collect
base
document
studi
referr
facil
prior
exposur
antibiot
zambia
high
due
health
system
structur
wherebi
children
hospitalis
assess
primari
care
facil
antibiot
administ
prior
transport
hospit
nonfer
gramneg
streptococci
enterococci
e
detect
base
npop
pcr
posit
except
pathogen
specifi
densiti
threshold
p
jirovecii
copiesml
h
influenza
copiesml
cmv
copiesml
pneumonia
copiesml
appendix
caus
sever
pneumonia
requir
hospit
admiss
children
without
hiv
infect
africa
asia
perch
multicountri
casecontrol
studi
supplementari
odd
ratio
adjust
age
month
site
b
odd
ratio
adjust
age
month
site
pathogen
quantifi
degre
associ
pneumonia
case
statu
pathogen
detect
person
otherwis
similar
respect
age
site
measur
pathogen
c
npop
pcr
threshold
p
jirovecii
copiesml
h
influenza
copiesml
cmv
copiesml
pneumonia
copiesml
high
densiti
pneumonia
defin
copiesml
npop
pcr
pneumococc
serotyp
determin
cultur
isol
quellung
method
pcr
npopcultur
neg
pcrposit
specimen
microarray
use
determin
serotyp
e
measl
pcr
test
done
use
singleplex
pcr
method
npop
viral
transport
medium
specimen
case
meet
one
follow
criteria
histori
measl
measl
admiss
diagnosi
measl
discharg
diagnosi
measl
rash
enrol
organ
abbrevi
cmv
cytomegaloviru
hbov
human
bocaviru
hmpv
human
metapneumoviru
pvev
parechovirusenteroviru
rsv
respiratori
syncyti
viru
note
adjust
made
odd
ratio
prior
antibiot
use
known
influenc
bacteri
posit
appendix
caus
sever
pneumonia
requir
hospit
admiss
children
without
hiv
infect
africa
asia
perch
multicountri
casecontrol
studi
page
b
number
organ
detect
npop
pcr
threshold
p
jirovecii
copiesml
h
influenza
copiesml
cmv
copiesml
pneumonia
copiesml
pvalu
logist
regress
adjust
site
age
month
analysi
includ
use
npop
pcr
threshold
p
jirovecii
copiesml
h
influenza
copiesml
cmv
copiesml
pneumonia
copiesml
gray
odd
ratio
adjust
age
month
site
black
odd
ratio
adjust
age
month
site
presenc
pathogen
npop
pcr
quantifi
degre
associ
pneumonia
case
statu
pathogen
detect
person
otherwis
similar
respect
age
site
measur
pathogen
note
adjust
made
odd
ratio
prior
antibiot
use
known
influenc
bacteri
posit
abbrevi
cmv
cytomegaloviru
hbov
human
bocaviru
hmpv
human
metapneumoviru
pvev
parechovirusenteroviru
rsv
respiratori
syncyti
viru
high
densiti
pneumonia
defin
copiesml
npop
pcr
pneumococc
serotyp
determin
cultur
isol
quellung
method
pcr
npopcultur
neg
pcrposit
specimen
microarray
use
determin
serotyp
b
measl
pcr
test
done
use
singleplex
pcr
method
npop
viral
transport
medium
specimen
case
meet
one
follow
criteria
histori
measl
measl
admiss
diagnosi
measl
discharg
diagnosi
measl
rash
enrol
npop
pcr
threshold
p
jirovecii
copiesml
h
influenza
copiesml
cmv
copiesml
pneumonia
copiesml
legionella
speci
anyinfluenza
b
influenza
c
measl
b
parainfluenza
page
supplementari
abbrevi
odd
ratio
ci
confid
interv
wb
whole
blood
cxr
chest
xray
posit
consolid
andor
infiltr
odd
ratio
adjust
site
age
month
site
lung
aspir
posit
case
gambia
south
africa
case
posit
lung
aspir
known
caus
account
final
popul
aetiolog
estim
use
result
updat
prior
distribut
remain
consolid
case
remain
case
use
pia
model
updat
aetiolog
prior
second
time
complet
analysi
case
case
posit
pleural
fluid
similarli
known
caus
due
small
number
remain
case
confirm
pleural
effus
cxr
without
pleural
fluid
find
posit
result
use
updat
aetiolog
prior
distribut
use
determin
aetiolog
posit
case
model
run
site
lung
aspir
posit
case
identifi
one
two
group
one
group
repres
lung
aspir
collect
case
consolid
cxr
second
group
case
infiltr
aetiolog
analysi
run
site
case
group
combin
allow
aetiolog
distribut
fals
posit
rate
vari
across
site
aetiolog
prior
vari
case
subgroup
within
site
eg
base
lung
aspir
pleural
fluid
data
data
inform
sensit
site
analysi
allow
estim
allsit
level
well
sitespecif
level
page
abbrevi
npop
nasopharyngealoropharyng
swab
pcr
polymeras
chain
reaction
pneu
streptococcu
pneumonia
mtb
mycobacterium
tuberculosi
induc
sputum
tuberculosi
analys
posit
assign
first
induc
sputum
first
gastric
aspir
induc
sputum
unavail
lung
aspir
result
restrict
specimen
obtain
within
day
enrol
pathogen
determin
clinic
review
team
noncontamin
case
posit
lung
aspir
known
caus
account
final
popul
aetiolog
estim
use
result
updat
prior
distribut
remain
consolid
case
page
supplementari
supplementari
tabl
descript
symbol
size
symbol
scale
base
ratio
estim
aetiolog
fraction
standard
error
two
ident
aetiolog
fraction
estim
estim
associ
larger
symbol
inform
data
appendix
caus
sever
pneumonia
requir
hospit
admiss
children
without
hiv
infect
africa
asia
perch
multicountri
casecontrol
studi
supplementari
descript
symbol
line
repres
credibl
interv
darker
region
line
repres
interquartil
rang
size
symbol
scale
base
ratio
estim
aetiolog
fraction
standard
error
two
ident
aetiolog
fraction
estim
estim
associ
larger
symbol
inform
data
page
supplementari
pathogen
figur
display
distribut
individu
case
probabl
pathogen
exclud
case
aetiolog
probabl
pathogen
scale
yaxi
display
children
higher
probabl
red
case
test
posit
pathogen
npop
pcr
wb
pcr
pneumonia
blue
case
test
neg
gray
case
miss
data
black
case
posit
silver
standard
specimen
ie
posit
lung
aspir
pleural
fluid
blood
cultur
case
one
pathogen
detect
silver
standard
specimen
evid
pneumonia
etiolog
due
pneumonia
base
three
independ
piec
inform
high
load
nasopharyngealoropharyng
npop
pcr
high
densiti
whole
blood
wb
pcr
blood
cultur
sensit
analysi
evalu
impact
lower
blood
cultur
sensit
prior
pneumonia
also
specifi
increas
certainti
midpoint
valu
sensit
prior
rang
decreas
approxim
chang
made
sensit
aetiolog
prior
sitespecif
observ
result
interpret
decreas
blood
cultur
sensit
prior
pneumonia
littl
impact
aetiolog
result
evid
pneumonia
aetiolog
due
pneumonia
base
three
independ
piec
inform
high
load
nasopharyngealoropharyng
npop
pcr
high
densiti
whole
blood
wb
pcr
blood
cultur
site
weak
blood
cultur
evid
ie
low
number
pneumococc
posit
isol
model
reli
evid
npop
wb
pcr
data
therefor
chang
blood
cultur
sensit
prior
minim
impact
blood
cultur
posit
site
blood
cultur
posit
case
still
limit
influenc
blood
cultur
sensit
prior
due
addit
contribut
data
pneumonia
provid
npop
pcr
wb
pcr
appendix
caus
sever
pneumonia
requir
hospit
admiss
children
without
hiv
infect
africa
asia
perch
multicountri
casecontrol
studi
sensit
analysi
evalu
impact
lower
sensit
prior
pneumococc
measur
result
higher
etiolog
estim
pneumococcu
also
specifi
increas
certainti
midpoint
valu
sensit
prior
rang
decreas
describ
chang
made
sensit
aetiolog
prior
blood
cultur
sensit
analysi
present
supplementari
figur
basecas
sensit
prior
lower
narrow
sensit
prior
ratio
base
lower
prior
antibiot
exposur
adequ
blood
volum
interpret
use
higher
aetiolog
prior
modestli
increas
pneumonia
aetiolog
compar
base
model
result
posterior
pneumonia
aetiolog
estim
rang
across
site
posterior
aetiolog
estim
pneumonia
consist
lower
aetiolog
prior
specifi
site
even
combin
aetiolog
prior
vt
nvt
pneumonia
site
introduc
pcv
zambia
thailand
bangladesh
result
posterior
aetiolog
estim
rang
sitespecif
observ
result
interpret
increas
aetiolog
prior
no
base
case
increas
aetiolog
attribut
no
site
except
thailand
evid
causal
weakest
result
posterior
no
estim
thailand
site
fewest
number
case
fewest
number
blood
cultur
posit
no
aetiolog
increas
base
find
demonstr
amount
pneumonia
due
pathogen
measur
no
determin
lack
evid
measur
pathogen
hard
quantifi
howev
also
demonstr
evid
data
measur
pathogen
suggest
no
like
less
prior
no
estim
lower
prior
site
except
thailand
weak
data
aetiolog
evid
precis
estim
no
possibl
rel
magnitud
aetiolog
measur
pathogen
remain
constant
regardless
assumpt
ie
distribut
pathogen
test
similar
appendix
caus
sever
pneumonia
requir
hospit
admiss
children
without
hiv
infect
africa
asia
perch
multicountri
casecontrol
studi
screen
perform
four
site
kilifi
sa
kaeo
nakhon
phanom
matlab
elig
consent
case
enrol
remain
site
screen
perform
establish
hour
elig
consent
case
present
predefin
screen
hour
enrol
except
mali
use
systemat
sampl
process
see
tabl
sitespecif
screen
hour
hospitalis
inclus
criterion
site
except
bangladesh
perch
studi
enrol
includ
children
recommend
hospitalis
admit
hospitalis
children
case
assess
occur
within
hour
admiss
major
children
admit
parent
refus
admiss
control
randomli
select
resid
studi
catchment
area
frequenc
match
case
age
group
month
month
month
month
age
site
aim
enrol
approxim
control
per
case
achiev
african
site
nakhon
phanom
thailand
aim
recruit
minimum
control
month
matlab
dhaka
bangladesh
aim
enrol
control
per
month
sa
kaeo
thailand
aim
enrol
control
per
month
month
number
case
exceed
target
control
enrol
site
enrol
addit
control
achiev
ratio
case
control
ratio
month
case
underw
comprehens
standardis
clinic
examin
admiss
hour
still
hospitalis
vital
statu
assess
day
respiratori
sign
anthropometri
level
conscious
oxygen
satur
room
air
whenev
possibl
record
among
sign
case
still
hospitalis
hour
admiss
underw
followup
clinic
assess
vital
statu
case
assess
followup
visit
phone
interview
conduct
day
admiss
window
day
control
similarli
assess
clinic
find
enrol
followup
assess
chest
radiograph
cxr
obtain
case
enrol
interpret
blind
site
clinic
factor
two
radiologist
paediatrician
train
standardis
interpret
paediatr
cxr
appendix
caus
sever
pneumonia
requir
hospit
admiss
children
without
hiv
infect
africa
asia
perch
multicountri
casecontrol
studi
cxr
classifi
consolid
infiltr
normal
uninterpret
cxr
obtain
day
follow
enrol
exclud
analys
film
routin
collect
would
reflect
clinic
progress
improvementdeterior
may
repres
nosocomi
diseas
lung
aspir
collect
perform
four
site
gambia
bangladesh
mali
south
africa
elig
case
larg
dens
peripher
consolid
cxr
contraind
lung
aspir
collect
includ
presenc
pneumatocoel
cxr
post
measl
pneumonia
patient
clinic
unstabl
determin
clinician
procedur
would
defer
stabilis
cardiorespiratori
resuscit
cpr
perform
within
last
hour
parent
refus
child
subject
lung
aspir
pleural
fluid
collect
minor
case
indic
attend
clinician
methodolog
obtain
pleural
fluid
follow
local
clinic
practic
guidelin
includ
standard
safeti
precaut
contraind
pleural
fluid
collect
includ
coagulopathi
thrombocytopenia
haemodynam
respiratori
instabl
unless
therapeut
thoracentesi
requir
manag
clinic
instabl
detail
lung
aspir
pleural
fluid
collect
result
publish
separ
antibiot
preexposur
defin
either
posit
serum
bioassay
enrol
case
control
cliniciandocu
antibiot
administr
referr
studi
hospit
prior
specimen
collect
case
children
defin
hivinfect
direct
viral
detect
age
hiv
seroposit
month
age
south
african
site
routin
clinic
practic
confirm
hivseroposit
case
month
age
use
molecular
test
includ
hiv
pcr
hiv
viral
load
test
children
month
age
posit
hiv
serolog
statu
confirm
use
molecular
test
other
defin
hivuninfect
includ
children
unknown
hiv
statu
case
control
mostli
kenya
gambia
mali
hiv
test
perform
tachypnoea
defin
breath
per
minut
bpm
children
month
age
bpm
children
month
bpm
children
month
hypoxaemia
defin
either
room
air
pulseoximetri
oxygen
satur
two
site
elev
metr
zambia
south
africa
site
child
treat
oxygen
absenc
room
air
oxygen
satur
read
fever
defin
control
consid
respiratori
tract
ill
rti
cough
observ
report
runni
nose
report
one
follow
ear
discharg
report
wheez
report
difficulti
breath
report
presenc
either
sore
throat
report
fever
observ
temperatur
report
fever
past
hour
specimen
collect
microbiolog
test
conduct
densiti
threshold
use
analys
describ
elsewher
brief
use
quantit
multiplex
polymeras
chain
reaction
pcr
ftd
kit
fasttrack
diagnost
sliema
malta
routin
cultur
test
nasopharyngealoropharyng
npop
swab
case
control
cultur
pneumonia
induc
sputa
case
gastric
aspir
case
mycobacteria
lung
aspir
case
gambia
bangladesh
mali
south
africa
site
pleural
fluid
case
blood
case
control
streptococcu
pneumonia
pcr
case
blood
cultur
case
control
also
test
antibiot
activ
serum
creactiv
protein
case
subset
control
refer
section
section
detail
laboratori
result
use
aetiolog
analysi
fast
track
diagnost
respiratori
pathogen
ftd
multiplex
pcr
kit
use
perch
studi
includ
follow
viral
bacteri
fungal
target
data
nasopharyngealoropharyng
swab
npop
pcr
target
use
analysi
except
klebsiella
pneumonia
moraxella
catarrhali
target
underw
addit
confirmatori
test
describ
klebsiella
pneumonia
posit
result
consid
invalid
poor
assay
specif
moraxella
catarrhali
target
summar
descript
npop
pcr
analys
exclud
aetiolog
analys
due
poor
specif
odd
ratio
significantli
less
inabl
determin
densiti
threshold
improv
specif
posit
associ
case
statu
catarrhali
commens
bacterium
caus
pneumonia
observ
commonli
among
control
among
case
evid
literatur
presenc
npop
may
protect
develop
pneumonia
hypothes
biolog
rational
child
microbiom
slant
toward
colon
catarrhali
may
compet
pathogen
organ
underli
assumpt
analyt
model
measur
np
signal
lung
statist
significantli
higher
rate
control
pneumonia
direct
conflict
assumpt
therefor
npop
data
provid
use
diagnost
evid
pneumonia
etiolog
use
legionella
speci
sampl
posit
legionella
speci
underw
confirmatori
pcr
test
use
differ
extract
method
due
contamin
origin
extract
reagent
one
posit
remain
follow
confirmatori
test
although
one
posit
sinc
systemat
test
legionella
speci
thought
potenti
caus
paediatr
pneumonia
includ
possibl
caus
aetiolog
analysi
handl
consist
across
site
includ
legionella
speci
posit
detect
quantit
pcr
densiti
threshold
appli
npop
pathogen
poor
specif
ie
odd
ratio
threshold
improv
distinct
case
control
could
identifi
pneumococcu
h
influenza
cytomegaloviru
pneumocysti
jirovecii
npop
measl
systemat
test
perch
studi
perch
studi
enrol
case
case
identifi
met
perch
studi
clinic
criteria
measl
test
histori
measl
past
month
measl
rash
measl
admiss
diagnosi
measl
discharg
diagnosi
npop
swab
case
test
measl
suspect
measl
case
test
posit
kenya
mali
either
admiss
discharg
diagnosi
measl
none
posit
cxr
sinc
measl
systemat
test
elect
remov
potenti
caus
aetiolog
analysi
simpli
describ
number
posit
identifi
perch
studi
four
case
exclud
aetiolog
analys
popul
aetiolog
distribut
quantit
pcr
densiti
threshold
appli
whole
blood
result
improv
distinct
preval
case
control
pneumococc
serotyp
determin
cultur
isol
quellung
andor
pcr
microarray
npop
specimen
npcultur
neg
pcrposit
pneumococc
serotyp
stratifi
vaccinetyp
vt
nonvaccin
type
nvt
base
inclus
pneumococc
conjug
vaccin
vt
serotyp
handl
mix
ambigu
serotyp
pneumococc
serotyp
result
mix
ambigu
follow
quellung
andor
pcr
unabl
resolv
studi
site
serotyp
quellung
reaction
refer
laboratori
nation
institut
communic
diseas
johannesburg
south
africa
institut
environment
scienc
research
esr
porirua
new
zealand
serotyp
pneumococc
isol
appendix
caus
sever
pneumonia
requir
hospit
admiss
children
without
hiv
infect
africa
asia
perch
multicountri
casecontrol
studi
steril
site
well
sampl
pneumococc
isol
np
swab
cultur
per
site
verifi
quellung
esr
laboratori
serotyp
microarray
pneumococc
serotyp
specimen
posit
npop
pcr
neg
nasopharyng
np
skim
milk
trypton
glucos
glycerin
medium
stgg
cultur
determin
microarray
test
sampl
pneumococc
npop
pcr
result
densiti
threshold
copiesml
prioritis
test
sampl
meet
criterion
serotyp
result
avail
microarray
multipl
pneumococc
serotyp
detect
sampl
test
microarray
output
microarray
provid
rel
abund
serotyp
detect
specimen
eg
microarray
result
adjud
perch
studi
investig
includ
perch
studi
laboratori
director
determin
final
serotyp
base
rel
abund
mix
serotyp
specimen
domin
serotyp
select
final
serotyp
result
pneumococc
serotyp
data
specimen
use
assist
serotyp
confirm
process
avail
addit
limit
number
culturepositivepcrposit
stgg
sampl
test
method
cultur
microarray
part
initi
valid
step
microarray
children
serotyp
result
cultur
test
use
final
serotyp
test
method
ident
result
two
method
blood
cultur
perform
site
laboratori
case
enrol
posit
specimen
underw
confirmatori
test
central
laboratori
summari
review
process
case
blood
cultur
data
organ
isol
blood
case
classifi
contamin
organ
isol
base
priori
list
contamin
see
tabl
remain
blood
cultur
posit
case
underw
individu
case
review
panel
perch
studi
senior
investig
determin
whether
organ
detect
like
caus
child
hospitalis
contamin
review
includ
clinic
laboratori
risk
factor
data
review
result
addit
case
classifi
contamin
organ
isol
total
case
one
pathogen
identifi
consid
plausibl
caus
hospitalis
similar
review
conduct
pcr
cultur
result
lung
aspir
pleural
fluid
specimen
plan
test
blood
cultur
alarm
posit
cultur
neg
binaxnow
assay
pneumococc
antigen
howev
implement
consist
site
case
met
criteria
test
seven
test
neg
addit
sampl
meet
criteria
test
two
posit
south
africa
describ
pneumococc
binaxnow
test
pleural
fluid
specimen
site
implement
pleural
fluid
specimen
test
binaxnow
assay
pneumococc
antigen
case
pleural
fluid
sampl
eight
test
three
posit
eight
case
test
three
posit
pneumonia
cultur
pcr
pleural
fluid
two
three
also
posit
binaxnow
among
test
pneumonia
neg
cultur
pcr
pleural
fluid
data
avail
cultur
pcr
none
binaxnow
posit
specimen
identifi
among
without
binaxnow
perform
addit
test
binaxnow
would
provid
diagnost
inform
alreadi
provid
blood
cultur
pleural
fluid
cultur
pleural
fluid
pcr
given
among
test
case
pneumonia
neg
cultur
pcr
none
binaxnow
posit
furthermor
among
children
test
binaxnow
aureu
pathogen
detect
pleural
fluid
cultur
provid
diagnost
inform
pathogen
pneumonia
aetiolog
analysi
three
case
posit
pneumococc
antigen
binaxnow
consid
confirm
pneumococc
case
case
posit
two
specimen
pleural
fluid
tabl
aetiolog
divid
evenli
pathogen
see
section
attempt
obtain
singl
sputum
specimen
case
south
africa
multipl
sputum
specimen
obtain
case
tuberculosi
test
part
routin
clinic
practic
situat
one
sputum
gastric
aspir
specimen
collect
first
specimen
result
mycobacterium
tuberculosi
use
henc
exampl
child
two
induc
sputum
specimen
three
gastric
aspir
submit
second
induc
sputum
specimen
posit
tuberculosi
cultur
case
deem
case
tuberculosi
induc
sputum
specimen
test
cultur
use
ftd
multiplex
pcr
major
pathogen
pcr
data
strongli
correl
npop
pcr
data
specimen
collect
control
could
estim
account
specif
assum
ie
silver
standard
measur
like
blood
cultur
given
lack
inform
specif
strong
correl
npop
pcr
data
conclud
data
would
meaning
contribut
improv
analysi
except
induc
sputum
cultur
tuberculosi
use
determin
aetiolog
estim
aetiolog
pneumonia
need
analyt
method
could
integr
multipl
specimen
test
result
case
control
develop
novel
analyt
method
call
bayesian
analysi
kit
etiolog
research
baker
nest
partial
latent
class
analysi
method
use
integr
perch
studi
data
estim
aetiolog
distribut
individu
case
popul
case
purpos
appendix
provid
addit
detail
relat
analyt
input
method
specif
perch
integr
analysi
pia
beyond
present
main
paper
section
describ
nuanc
relat
specimen
laboratori
measur
pathogen
includ
integr
aetiolog
analysi
gold
none
blood
cultur
follow
clinic
review
remov
contamin
pleural
fluid
lung
aspir
cultur
pcr
follow
clinic
review
remov
contamin
updat
aetiolog
prior
case
consolid
lung
aspir
result
manual
updat
individu
probabl
pleural
fluid
lung
aspir
posit
case
induc
sputum
cultur
mtb
posit
first
specimen
first
gastric
aspir
unavail
npop
pcr
densiti
threshold
follow
target
pneumonia
copiesml
h
influenza
h
influenza
type
b
copiesml
cmv
copiesml
pcp
copiesml
ignor
npop
pcr
data
moraxella
catarrhali
klebsiella
pneumonia
see
section
laboratori
procedur
wb
pcr
pneumonia
densiti
threshold
copiesml
coronaviru
measur
separ
target
group
coronavirus
aetiolog
analysi
addit
bacteria
detect
blood
cultur
correspond
npop
pcr
measur
use
aetiolog
analysi
describ
section
ftd
panel
includ
organ
group
target
level
eg
hmpv
ab
rsv
ab
organ
split
across
multipl
target
eg
parainfluenza
type
influenza
b
c
analys
perform
use
result
target
wherev
possibl
oppos
group
across
target
given
organ
except
coronaviru
group
across
target
coronavirus
due
low
number
posit
anoth
except
pneumonia
appli
serotyp
data
subsequ
split
pneumococcu
relev
subgroup
eg
vs
rather
analys
pneumococc
serotyp
separ
would
spread
data
thinli
aetiolog
result
pathogen
estim
subspeci
level
subsequ
aggreg
speci
level
present
figur
tabl
note
analysi
equal
aetiolog
prior
pathogen
pathogen
posthoc
group
eg
influenza
aggreg
larger
cumul
aetiolog
prior
pathogen
without
subspeci
fasttrack
target
subspeci
level
eg
influenza
viru
time
aetiolog
prior
rhinoviru
influenza
type
abc
given
aetiolog
prior
rhinoviru
output
combin
influenza
viru
pia
bayesian
analysi
need
specifi
start
valu
distribut
aetiolog
fraction
aetiolog
prior
distribut
reduc
priori
bia
use
uninform
aetiolog
prior
wherein
pathogen
test
equal
start
probabl
caus
studi
aetiolog
prior
pathogen
ie
pathogen
plu
otherwis
specifi
no
categori
symmetr
dirichlet
distribut
hyperparamet
exchang
natur
symmetr
dirichlet
prior
treat
pathogen
equal
like
import
caus
prior
updat
perch
studi
data
distribut
uncertainti
around
aetiolog
prior
also
specifi
ie
fix
point
estim
assum
major
pneumonia
case
caus
subset
pathogen
without
specif
indic
pathogen
implement
use
small
hyperparamet
make
prior
distribut
flexibl
prior
uncertainti
larger
contrast
larger
valu
even
assumpt
organ
includ
analysi
tabl
nonzero
aetiolog
fraction
estim
analysi
contrast
analyt
approach
exclud
pathogen
associ
case
statu
abbrevi
pneumococc
conjug
vaccin
lung
aspir
pleural
fluid
specimen
provid
valuabl
inform
child
pneumonia
caus
children
inform
extrapol
result
children
would
challeng
small
number
repres
fraction
case
eg
result
pleural
fluid
repres
children
pleural
effus
pneumonia
case
section
describ
method
use
incorpor
valuabl
inform
integr
aetiolog
analysi
done
updat
aetiolog
prior
subset
repres
case
three
primari
challeng
incorpor
lung
aspir
pleural
fluid
data
analysi
case
avail
specimen
subset
posit
children
posit
mani
posit
multipl
organ
creat
conflict
pia
assumpt
singlepathogen
caus
test
result
specimen
specif
obtain
lung
aspir
pleural
fluid
specimen
child
determin
base
strict
clinic
characterist
therefor
children
unlik
clinic
aetiolog
repres
perch
studi
case
made
four
key
decis
determin
lung
aspir
pleural
fluid
data
use
analysi
determin
caus
latent
unknown
case
instead
use
silver
standard
measur
direct
input
pia
model
case
would
miss
data
posit
result
use
updat
uniform
aetiolog
prior
valu
pathogen
detect
silver
standard
measur
higher
probabl
caus
process
done
sitespecif
basi
ie
distribut
pathogen
found
appli
case
site
updat
aetiolog
prior
appli
subset
case
deem
repres
correspond
specimen
obtain
see
next
section
given
small
number
case
pleural
effus
confirm
chest
xray
rang
across
site
would
repres
pleural
fluid
specimen
decid
use
pleural
fluid
data
updat
aetiolog
prior
done
lung
aspir
posit
case
analyt
group
would
appli
small
robust
analysi
ie
requir
stratifi
analysi
confirm
case
pleural
fluid
result
use
inform
individu
aetiolog
extrapol
case
case
posit
lung
aspir
pleural
fluid
result
one
pathogen
detect
aetiolog
apport
equal
across
pathogen
decis
requir
us
defin
subgroup
case
repres
specimen
obtain
lung
aspir
identifi
case
consolid
chest
radiograph
cxr
elig
criterion
obtain
specimen
analyz
separ
updat
aetiolog
prior
use
lung
aspir
result
lung
aspir
result
use
updat
aetiolog
prior
restrict
follow
criteria
specimen
obtain
within
day
enrol
exclud
nosocomi
infect
posit
result
confirm
caus
child
pneumonia
silver
standard
work
group
see
section
base
clinic
present
cours
treatment
laboratori
data
eg
weakli
posit
pcr
result
exclud
child
hiv
primari
analysi
exclud
hiv
children
inform
aetiolog
prior
follow
rule
appli
elig
specimen
determin
updat
aetiolog
prior
use
pia
tabl
abbrevi
la
lung
aspir
pneumococc
conjug
vaccin
use
noninform
valu
sensit
ie
uniform
likelihood
contradict
belief
npop
pcr
highli
sensit
ie
like
greater
detect
pathogen
given
lung
b
blood
cultur
bcx
poorli
sensit
ie
like
less
sensit
prior
pathogentest
select
priori
analys
perch
studi
data
intern
work
group
avail
inform
extern
perch
studi
evalu
determin
sensit
measur
develop
sensit
prior
refer
diagnost
sensit
given
organ
probabl
test
correctli
identifi
children
pneumonia
caus
organ
section
detail
final
sensit
prior
pathogentest
combin
well
process
develop
prior
pia
integr
sensit
prior
distribut
observ
data
chang
updat
prior
contribut
studi
data
result
posterior
sensit
estim
pathogentest
combin
appendix
caus
sever
pneumonia
requir
hospit
admiss
children
without
hiv
infect
africa
asia
perch
multicountri
casecontrol
studi
blood
cultur
final
sensit
prior
pathogen
measur
blood
cultur
summar
section
follow
describ
inform
use
inform
sensit
prior
diagnost
sensit
blood
cultur
common
pneumonia
pathogen
associ
bacteraemia
typic
concentr
least
cfuml
therefor
ml
blood
inocul
blood
cultur
bottl
high
sensit
estim
detect
pathogen
given
enter
blood
one
bacterium
bottl
need
eventu
alarm
blood
cultur
instrument
antibiot
pretreat
contamin
lower
estim
skin
contamin
cultur
sensit
detect
pathogen
blood
assum
microbi
identif
accur
therefor
sensit
blood
cultur
detect
pathogen
lung
driven
primarili
preval
bacteraemia
direct
evid
diagnost
sensit
streptococcu
pneumonia
haemophilu
influenza
vaccin
probe
studi
see
section
estim
pathogen
set
base
blood
cultur
sensit
prior
except
salmonella
speci
enterobacteriacea
neisseria
meningitidi
select
wider
prior
reflect
greater
uncertainti
result
pneumococc
conjug
vaccin
pcv
trial
south
africa
gambia
reanalys
restrict
perchlik
condit
ie
sever
sever
pneumonia
case
estim
number
pneumococc
blood
cultur
confirm
case
rel
pneumococc
pneumonia
case
ie
estim
percent
pneumococc
pneumonia
case
bacteraem
number
pneumococc
blood
cultur
confirm
case
numer
estim
number
bcx
pneumococcu
control
group
met
perch
studi
case
definit
denomin
estim
number
perchlik
pneumonia
control
group
bcx
taken
multipli
vaccin
efficaci
perchdefin
pneumonia
adjust
vaccin
efficaci
vaccinetyp
bcx
percent
bcx
vaccinetyp
result
south
africa
gambia
wide
confid
interv
due
small
number
vaccinetyp
bcx
control
sa
gambia
also
conduct
sensit
analysi
assum
vaccin
efficaci
vaccinetyp
pneumonia
lower
nonbacteraem
case
bcx
case
south
africa
gambia
result
south
africa
gambia
restrict
analys
cxr
case
reduc
sampl
size
vaccinetyp
bcx
control
south
africa
small
analys
gambia
produc
similar
result
case
sensit
analysi
take
lowest
highest
valu
four
result
round
impact
prior
antibiot
account
analys
adjust
pia
see
section
produc
rang
similar
reanalysi
exercis
intend
h
influenza
use
result
gambian
hib
probe
trial
howev
data
year
old
trial
could
locat
given
similar
pneumococcu
elect
appli
pneumonia
blood
cultur
prior
h
influenza
antibiot
exposur
prior
specimen
collect
low
blood
volum
reduc
pathogen
detect
blood
cultur
bacteria
approxim
therefor
halv
sensit
prior
blood
cultur
children
evid
either
factor
analysi
prior
antibiot
exposur
defin
either
posit
serum
antibiot
bioassay
clinician
report
antibiot
administ
prior
specimen
collect
low
blood
volum
defin
ml
adjust
sensit
prior
midpoint
origin
specifi
sensit
prior
rang
calcul
eg
midpoint
sensit
prior
rang
pneumonia
halv
beta
distribut
appli
halv
midpoint
construct
adjust
rang
specifi
two
paramet
beta
probabl
densiti
mode
midpoint
sensit
tabl
children
miss
data
prior
antibiot
exposur
andor
blood
volum
develop
rule
handl
miss
data
base
result
children
data
site
tabl
proport
case
adequ
blood
volum
prior
antibiot
use
children
miss
data
assum
adequ
blood
volum
prior
antibiot
use
chang
made
sensit
prior
children
miss
data
assum
low
blood
volum
prior
antibiot
use
sensit
prior
halv
proport
assumpt
could
made
statu
children
miss
data
ie
unknown
statu
sensit
prior
rang
widen
minimum
adjust
rang
maximum
base
rang
reflect
uncertainti
red
set
unknown
case
miss
data
appendix
caus
sever
pneumonia
requir
hospit
admiss
children
without
hiv
infect
africa
asia
perch
multicountri
casecontrol
studi
unknown
prior
antibiot
use
unknown
blood
volum
south
africa
unknown
prior
antibiot
use
unknown
blood
volum
use
wider
sensit
prior
rang
span
minimum
adjust
rang
maximum
base
rang
reflect
uncertainti
final
sensit
prior
pathogen
measur
npop
pcr
summar
sensit
also
like
high
base
evid
set
lower
bound
sensit
prior
pathogen
salmonella
speci
legionella
speci
evid
regard
frequenc
colonis
wide
sensit
prior
rang
select
relev
pathogen
appli
pcr
densiti
threshold
like
decreas
percentag
confirm
case
posit
npop
pcr
evid
perch
studi
data
evalu
perch
studi
data
directli
use
pia
provid
addit
evid
base
npop
pcr
sensit
prior
eight
case
posit
lung
aspir
cultur
andor
pcr
pneumonia
seven
npop
pcr
data
posit
pneumonia
five
densiti
threshold
copiesml
two
case
densiti
threshold
copiesml
respect
evid
prior
antibiot
use
sensit
prior
rang
chang
midpoint
midpoint
analysi
prior
antibiot
exposur
defin
either
posit
serum
bioassay
case
control
clinician
report
antibiot
administ
prior
specimen
collect
case
two
induc
sputum
specimen
routin
obtain
case
perch
studi
south
africa
site
order
estim
sensit
mtb
cultur
use
capturerecaptur
method
compar
first
second
induc
sputum
result
use
method
sensit
singl
specimen
estim
howev
set
high
hiv
preval
may
higher
sensit
standard
think
sensit
sputum
gastric
aspir
upper
bound
lower
bound
base
discuss
execut
committe
decid
south
africa
perch
studi
estim
high
mtb
preval
set
might
high
appli
site
group
decid
use
standard
sensit
prior
mtb
site
ie
high
rate
tb
well
low
rate
lung
aspir
pleural
fluid
data
use
estim
aetiolog
case
posit
result
extrapol
lung
aspir
data
case
unknown
aetiolog
result
use
updat
aetiolog
prior
case
site
clinic
repres
specimen
obtain
see
section
sensit
prior
relev
paramet
data
analysi
sensit
pneumococc
wb
pcr
estim
compar
fraction
blood
cultur
posit
specimen
also
pcr
posit
perch
studi
among
case
pneumococcu
detect
blood
cultur
pneumococcu
detect
pcr
whole
blood
reduc
slightli
appli
optim
quantit
pcr
load
threshold
observ
similar
proport
pneumonia
case
enrol
pilot
studi
kilifi
site
integr
aetiolog
analysi
estim
sensit
wb
given
blood
cultur
posit
also
use
set
prior
data
would
incorpor
twice
therefor
determin
sensit
prior
wb
pcr
consid
evid
lung
aspir
pleural
fluid
specimen
children
posit
pleural
fluid
specimen
like
differ
posit
lung
aspir
sinc
advanc
state
pathogen
abl
travel
outsid
lung
pleural
space
like
higher
sensit
detect
pneumococcu
whole
blood
ie
like
pathogen
also
move
blood
pneumonia
case
inde
evid
data
support
hypothesi
sinc
high
densiti
wb
pcr
among
case
posit
pneumococcu
pleural
fluid
lung
aspir
start
noninform
sensit
rang
distribut
beta
updat
rang
use
lung
aspir
pleural
fluid
data
case
consolid
repres
lung
aspir
specimen
obtain
posit
lung
aspir
case
result
updat
sensit
prior
rang
given
small
number
case
pleural
effus
pleural
fluid
result
would
appli
absenc
data
inform
sensit
prior
case
infiltr
normal
cxr
find
appli
lung
aspir
rang
case
sensit
prior
streptococcu
pneumonia
partial
latent
class
model
perch
integr
analysi
pia
baker
method
use
integr
blood
cultur
induc
sputum
tb
result
case
npop
pcr
wb
pneumococc
pcr
result
case
control
estim
aetiolog
distribut
individu
case
popul
case
probabl
organ
rang
pia
model
run
determin
aetiolog
latent
case
ie
without
known
aetiolog
children
known
aetiolog
handl
differ
describ
figur
tabl
use
within
model
inform
aetiolog
latent
case
blood
cultur
posit
one
pathogen
green
box
b
singl
case
posit
two
bacteria
blood
cultur
salmonella
speci
streptococcu
pyogen
handl
separ
model
blood
cultur
assum
specif
model
use
inform
individu
child
aetiolog
lung
aspir
posit
green
box
c
exclud
model
run
append
output
dataset
inform
individu
child
aetiolog
lung
aspir
result
use
updat
aetiolog
prior
distribut
remain
case
xray
consolid
use
multinomi
likelihood
inform
popul
aetiolog
ye
updat
aetiolog
prior
pleural
fluid
posit
green
box
exclud
model
run
append
output
dataset
inform
individu
child
aetiolog
due
small
number
latent
case
confirm
pleural
effus
cxr
ie
pleural
fluid
result
would
applic
see
section
posit
result
use
updat
aetiolog
prior
distribut
measl
green
box
exclud
analysi
describ
separ
ie
append
final
aetiolog
distribut
see
section
ye
two
case
whose
pleural
fluid
posit
also
blood
cultur
posit
pathogen
detect
pleural
fluid
remain
pia
model
blood
cultur
data
could
inform
aetiolog
case
pleural
fluid
result
use
input
measur
reason
describ
estim
allsit
aetiolog
attribut
main
paper
figur
singl
model
run
includ
case
control
site
adjust
site
age
age
year
age
year
adjust
consist
stratifi
case
control
within
model
age
site
allow
aetiolog
vari
strata
includ
site
age
strata
singl
model
ie
instead
run
separ
siteag
stratifi
model
enabl
estim
allsitescombin
aetiolog
estim
across
strata
algorithm
use
stratumspecif
blood
cultur
data
preval
odd
ratio
npop
pcr
pneumococc
wb
pcr
inform
aetiolog
time
algorithm
updat
sensit
prior
measur
combin
evid
across
siteag
strata
obtain
posterior
sensit
valu
measur
exampl
model
updat
pneumonia
npop
pcr
sensit
site
pneumonia
posit
blood
cultur
base
fraction
pneumonia
posit
blood
cultur
case
site
also
pneumonia
posit
npop
pcr
site
posit
lung
aspir
data
gambia
south
africa
case
categor
repres
lung
aspir
specimen
collect
versu
aetiolog
prior
updat
use
result
subset
case
repres
lung
aspir
respect
site
gambia
south
africa
inform
distribut
pathogen
detect
lung
aspir
purpl
box
figur
see
section
aetiolog
prior
updat
site
without
lung
aspir
data
tabl
analys
run
iter
first
exclud
burnin
stage
remain
sampl
everi
th
iter
averag
obtain
aetiolog
probabl
distribut
case
rang
pathogen
iter
analysi
pia
assign
case
specif
pathogen
base
measur
measur
popul
case
control
measur
sensit
aetiolog
prior
bayesian
model
unknown
paramet
estim
true
caus
infect
child
aetiolog
sensit
measur
set
unknown
assum
follow
joint
prior
distribut
repres
prior
uncertainti
valu
markov
chain
mont
carlo
mcmc
estim
method
simul
larg
number
valu
unknown
posterior
distribut
given
observ
data
simul
estim
aetiolog
pathogen
approxim
averag
individu
case
probabl
provid
credibl
interv
cri
bayesian
analogu
confid
interv
converg
check
repeat
analysi
multipl
time
use
differ
start
seed
valu
compar
posterior
distribut
run
case
known
aetiolog
exclud
model
see
figur
tabl
append
output
dataset
model
iter
aetiolog
probabl
assign
follow
case
pathogen
detect
assign
aetiolog
detect
iter
case
pathogen
detect
assign
aetiolog
detect
aetiolog
assign
given
pathogen
distribut
equal
across
iter
rel
number
pathogen
detect
exampl
case
two
pathogen
detect
pathogen
b
would
iter
indic
aetiolog
pathogen
remain
iter
indic
aetiolog
pathogen
b
estim
aetiolog
result
stratifi
age
sever
singl
analysi
run
site
combin
includ
site
caselevel
cxr
strata
describ
stratifi
variabl
interest
ie
age
sever
regress
compon
allow
aetiolog
vari
strata
stratumspecif
estim
eg
age
year
age
year
individu
site
sever
sever
calcul
addit
calcul
estim
combin
across
strata
describ
evalu
pathogen
aetiolog
distribut
pneumonia
case
vari
site
standardis
sitespecif
aetiolog
distribut
age
pneumonia
sever
strata
accord
world
health
organ
definit
use
use
averag
age
sever
distribut
across
site
standard
age
sever
breakdown
amongst
cxrhivcas
tabl
hivcas
tabl
site
averag
across
site
shown
given
similar
case
mix
cxrhivand
hivcas
elect
use
case
mix
standardis
analys
standardis
result
iter
mcmc
posterior
sampl
assign
case
weight
accord
standardis
distribut
defin
weight
base
individu
covari
profil
popul
level
aetiolog
result
estim
site
use
weight
dataset
result
present
paper
observ
standardis
averag
distribut
age
sever
strata
across
site
appendix
caus
sever
pneumonia
requir
hospit
admiss
children
without
hiv
infect
africa
asia
perch
multicountri
casecontrol
studi
